人工智能在诊断,预测和治疗勃起功能障碍中的利用和前景
Bo Zhang1, Hui Wang2, Zitong Wang1
1Urology Department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
Sexual medicine
|February 19, 2026
概括
人工智能 (AI) 在通过智能工具和个性化护理改善勃起功能障碍 (ED) 诊断和治疗方面表现有前途. 必须解决数据隐私等挑战,以实现广泛的临床采用.
科学领域:
- 男人的健康 男人的健康
- 医疗人工智能 医疗人工智能
- 数字健康数字健康
背景情况:
- 勃起功能障碍 (ED) 是越来越多的人的健康问题,特别是老龄化人口.
- 人工智能 (AI) 为ED诊断和治疗提供了新的解决方案.
研究的目的:
- 系统地审查人工智能在ED管理中的作用.
- 检查人工智能在ED护理中的发展,应用,好处和挑战.
主要方法:
- 主要数据库 (PubMed,科学网,CNKI/万芳) 的PRISMA指导系统审查,截至2025年6月19日.
- 分析重点是人工智能的技术发展,临床应用 (诊断,预测,个性化治疗) 和大型语言模型 (LLM).
主要成果:
- 人工智能在ED方面取得了重大进展,通过智能问卷和可穿戴设备提供精确的诊断.
- 人工智能在个性化治疗开发和疾病进展预测方面表现出有效性.
- 大型语言模型 (LLM) 显示出新兴的潜力,但仍然存在关键挑战.
结论:
- 人工智能为改变男性医疗保健,特别是ED管理提供了坚实的基础.
- 人工智能增强了ED的诊断,个性化治疗和预测能力.
- 在ED中临床采用AI需要解决数据隐私,伦理和互操作性问题.
相关概念视频
Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Issues And Trends In Healthcare Delivery System
6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
633
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
633


